ZVSA
USDZyVersa Therapeutics Inc. Common Stock
$0.145+0.009 (6.618%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$0.136
Máximo
$0.145
Mínimo
$0.136
Volumen
0.00M
Fundamentos de la Empresa
Capitalización de Mercado
1.2M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.04M
Bolsa
OQB
Moneda
USD
Rango de 52 Semanas
Mínimo $0.11Actual $0.145Máximo $1.95
Noticias Relacionadas
GlobeNewswire
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke.Cardiovascular
Ver más
GlobeNewswire
ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression
ZyVersa is developing Cholesterol Efflux Mediator™ VAR 200 to mediate removal of damaging excess cholesterol and other lipids from the kidneys' filtration system. VAR 200 directly removes lipids from kidney cells,
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.